Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter

American Journal of Physiology - Renal Physiology

Volumn 296, Issue 3, 2009, Pages

  Inscho, Edward W ^a   Cook, Anthony K ^a   Webb, R Clinton ^a   Jin, Li Ming ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ATP; Autoregulation; P2 receptors; Y 27632

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ANGIOTENSIN II; PURINERGIC P2X1 RECEPTOR; RHO KINASE; RHO KINASE INHIBITOR;

ANIMAL TISSUE; ARTERIOLE; ARTERY DIAMETER; ARTICLE; AUTOREGULATION; CALCIUM TRANSPORT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DOSE REDUCTION; IN VITRO STUDY; KIDNEY; MALE; MOBILIZATION; MOLECULAR DYNAMICS; NEPHRON; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RAT; SENSITIZATION; VASOCONSTRICTION; WESTERN BLOTTING;

AMIDES; ANIMALS; ARTERIOLES; CALCIUM; HOMEOSTASIS; KIDNEY; MALE; PRESSURE; PURINERGIC P2 RECEPTOR AGONISTS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; RHO-ASSOCIATED KINASES; VASOCONSTRICTION;

EID: 66049160044     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90703.2008     Document Type: Article

References (71)

1. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli L, Gachet C, Jacobson KA, Weisman GA. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58: 281-341, 2006. (Pubitemid 44394905)
2. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, Matsuura Y, Kaibuchi K. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 271: 20246, 1996. (Pubitemid 26281788)
3. Batchelor TJP, Sadaba JR, Ishola A, Pacaud P, Munsch CM, Beech DJ. Rho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary artery. Br J Pharmacol 132: 302-308, 2001. (Pubitemid 32128461)
4. Bell PD. Calcium antagonists and intrarenal regulation of glomerular filtration rate. Am J Nephrol 7: 24-31, 1987.
5. Boeynaems JM, Communi D, Gonzalez NS, Robaye B. Overview of the P2 receptors. Semin Thromb Hemost 31: 139-149, 2005. (Pubitemid 40605189)
6. Bolz SS, Vogel L, Sollinger D, Derwand R, De Wit C, Loirand G, Pohl U. Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway. Circulation 107: 3081, 2003. (Pubitemid 36758983)
7. Burnstock G. Purinergic signalling. Br J Pharmacol 147: S172-S181, 2006. (Pubitemid 43077275)
8. 2+] in renal arterioles. Am J Physiol Renal Fluid Electrolyte Physiol 265: F677-F685, 1993.
9. Carmines PK, Inscho EW, Gensure RC. Arterial pressure effects on preglomerular microvasculature of juxtamedullary nephrons. Am J Physiol Renal Fluid Electrolyte Physiol 258: F94-F102, 1990.
10. Carmines PK, Mitchell KD, Navar LG. Effects of calcium antagonists on renal hemodynamics and glomerular function. Kidney Int 41, Suppl 36: S43-S48, 1992.
11. Carmines PK, Navar LG. Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG II. Am J Physiol Renal Fluid Electrolyte Physiol 256: F1015-F1020, 1989.
12. Casellas D, Carmines PK. Control of the renal microcirculation: cellular and integrative perspectives. Curr Opin Nephrol Hypertens 5: 57-63, 1996. (Pubitemid 26088562)
13. Cavarape A, Bauer J, Bartoli E, Endlich K, Parekh N. Effects of angiotensin II, arginine vasopressin and tromboxane A2 in renal vascular bed: role of rho-kinase. Nephrol Dial Transplant 18: 1764-1769, 2003. (Pubitemid 37098546)
14. Cavarape A, Endlich N, Assaloni R, Bartoli E, Steinhausen M, Parekh N, Endlich K. Rho-kinase inhibition blunts renal vasoconstriction induced by distinct signaling pathways in vivo. J Am Soc Nephrol 14: 37-45, 2003. (Pubitemid 36026295)
15. Chaulet H, Desgranges C, Renault MA, Dupuch F, Ezan G, Peiretti F, Loirand G, Pacaud P, Gadeau AP. Extracellular nucleotides induce arterial smooth muscle cell migration via osteopontin. Circ Res 89: 772-778, 2001. (Pubitemid 34633847)
16. Chitaley K, Weber D, Webb RC. RhoA/Rho-kinase, vascular changes, and hypertension. Curr Hypertens Rep 3: 139-144, 2001.
17. Cipolla MJ, Gokina NI, Osol G. Pressure-induced actin polymerization in vascular smooth muscle as a mechanism underlying myogenic behavior. FASEB J 16: 72-76, 2002. (Pubitemid 34027952)
18. Conger JD, Falk SA. KCl and angiotensin responses in isolated rat renal arterioles: effects of diltiazem and low-calcium medium. Am J Physiol Renal Fluid Electrolyte Physiol 264: F134-F140, 1993.
19. Conger JD, Falk SA, Robinette JB. Angiotensin II-induced changes in smooth muscle calcium in rat renal arterioles. J Am Soc Nephrol 3: 1792-1803, 1993.
20. Gonzalez E, Salomonsson M, Kornfeld M, Gutierrez AM, Morsing P, Persson AEG. Different action of angiotensin II and noradrenaline on cytosolic calcium concentration in isolated and perfused afferent arterioles. Acta Physiol Scand 145: 299-300, 1992.
21. Griffin KA, Picken M, Bakris GL, Bidani AK. Comparative effects of selective T- and L-type calcium channel blockers in the remnant kidney model. Hypertension 37: 1268-1272, 2001. (Pubitemid 34163580)
22. Hayashi K, Epstein M, Loutzenhiser R. Pressure-induced vasoconstriction of renal microvessels in normotensive and hypertensive rats: studies in the isolated perfused hydronephrotic kidney. Circ Res 65: 1475-1484, 1989. (Pubitemid 20023543)
23. Huang C, Davis G, Johns EJ. Effect of nitrendipine on autoregulation of perfusion in the cortex and papilla of kidneys from Wistar and stroke prone spontaneously hypertensive rats. Br J Pharmacol 111: 111-116, 1994. (Pubitemid 24148713)
24. 2+ from intracellular stores. Gen Pharmacol 34: 409-415, 2001.
25. Inscho EW, Cook AK. P2 receptor-mediated afferent arteriolar vasoconstriction during calcium channel blockade. Am J Physiol Renal Physiol 282: F245-F255, 2002.
26. 1 receptors in renal microvascular autoregulatory behavior. J Clin Invest 112: 1895-1905, 2003.
27. Inscho EW, Cook AK, Imig JD, Vial C, Evans RJ. Renal autoregulation in P2X1 knockout mice. Acta Physiol Scand 181: 445-453, 2004. (Pubitemid 39078841)
28. Inscho EW, Cook AK, Mui V, Imig JD. Calcium mobilization contributes to pressure-mediated afferent arteriolar vasoconstriction. Hypertension 31: 421-428, 1998. (Pubitemid 28124752)
29. Inscho EW, Cook AK, Mui V, Miller J. Direct assessment of renal microvascular responses to P2-purinoceptor agonists. Am J Physiol Renal Physiol 274: F718-F727, 1998. (Pubitemid 28217789)
30. 2-purinoceptor activation. Am J Physiol Renal Fluid Electrolyte Physiol 271: F1077-F1085, 1996.
31. 2+ from intracellular stores. Hypertension 29: 222-227, 1997.
32. Inscho EW, LeBlanc EA, Pham BT, White SM, Imig JD. Purinoceptor-mediated calcium signaling in preglomerular smooth muscle cells. Hypertension 33: 195-200, 1999.
33. Inscho EW, Ohishi K, Cook AK, Belott TP, Navar LG. Calcium activation mechanisms in the renal microvascular response to extracellular ATP. Am J Physiol Renal Fluid Electrolyte Physiol 268: F876-F884, 1995.
34. 2+ signaling in preglomerular smooth muscle cells. Am J Physiol Renal Physiol 276: F450-F456, 1999.
35. 2+ sensitization and mobilization by MCh in tracheal smooth muscle. Am J Physiol Lung Cell Mol Physiol 280: L1218-L1224, 2001.
36. Iversen BM, Arendshorst WJ. ANG II and vasopressin stimulate calcium entry in dispersed smooth muscle cells of preglomerular arterioles. Am J Physiol Renal Physiol 274: F498-F508, 1998.
37. Just A. Mechanisms of renal blood flow autoregulation: dynamics and contributions. Am J Physiol Regul Integr Comp Physiol 292: R1-R17, 2007. (Pubitemid 46089813)
38. 2+ and protein kinase C in developing myogenic contraction in isolated rat small arteries. Am J Physiol Heart Circ Physiol 272: H1165-H1172, 1997.
39. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuko M, Yamamori B, Iwamatsu A, Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273: 245-248, 1996. (Pubitemid 26285892)
40. Kornfeld M, Gutierrez AM, Gonzalez E, Salomonsson M, Persson AEG. Cell calcium concentration in glomerular afferent and efferent arterioles under the action of noradrenaline and angiotensin II. Acta Physiol Scand 151: 99-105, 1994. (Pubitemid 2079018)
41. Loutzenhiser R, Epstein M. Modification of the renal hemodynamic response to vasoconstrictors by calcium antagonists. Am J Nephrol 7: 7-16, 1987. (Pubitemid 18029962)
42. Loutzenhiser R, Epstein M, Hayashi K. Renal hemodynamic effects of calcium channel antagonists. Am J Cardiol 64: 41F-45F, 1989. (Pubitemid 19237947)
43. Loutzenhiser R, Epstein M, Horton C. Inhibition by diltiazem of pressure-induced afferent vasoconstriction in the isolated perfused rat kidney. Am J Cardiol 59: 72A-75A, 1987. (Pubitemid 17023342)
44. Loutzenhiser R, Griffin K, Williamson G, Bidani A. Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul Integr Comp Physiol 290: R1153-R1167, 2006.
45. MacDonald JA, Borman MA, Murányi A, Somlyo AV, Hartshorne DJ, Haystead TAJ. Identification of the endogenous smooth muscle myosin phosphatase-associated kinase. Proc Natl Acad Sci USA 98: 2419-2424, 2001. (Pubitemid 32209497)
46. Macrez-Lepretre N, Morel JL, Mironneau J. Angiotensin II-mediated activation of L-type calcium channels involves phosphatidylinositol hydrolysis-independent activation of protein kinase C in rat portal vein myocytes. J Pharmacol Exp Ther 278: 468-475, 1996. (Pubitemid 27167008)
47. Majid DSA, Inscho EW, Navar LG. P2 purinoceptor saturation by adenosine triphosphate impairs renal autoregulation in dogs. J Am Soc Nephrol 10: 492-498, 1999.
48. Martinka P, Lai EY, Fahling M, Jankowski V, Jankowski J, Schubert R, Gaestel M, Persson AEG, Persson PB, Patzak A. Adenosine increases calcium sensitivity via receptor-independent activation of the p38/MK2 pathway in mesenteric arteries. Acta Physiol (Oxf) 193: 37-46, 2008.
49. Mitchell KD, Navar LG. Tubuloglomerular feedback responses during peritubular infusions of calcium channel blockers. Am J Physiol Renal Fluid Electrolyte Physiol 258: F537-F544, 1990.
50. Nakamura A, Hayashi K, Ozawa Y, Fujiwara K, Okubo K, Kanda T, Wakino S, Saruta T. Vessel- and vasoconstrictor-dependent role of rho/rho-kinase in renal microvascular tone. J Vasc Res 40: 244-251, 2003. (Pubitemid 36980726)
51. Navar LG, Arendshorst WJ, Pallone TL, Inscho EW, Imig JD, Bell PD. The renal microcirculation. In: Handbook of Physiology: Microcirculation, edited by Tuma RF, Duran WN, and Ley K. San Diego, CA: Elsevier, 2008, p. 550-683.
52. Navar LG, Champion WJ, Thomas CE. Effects of calcium channel blockade on renal vascular resistance responses to changes in renal perfusion pressure and angiotensin-converting enzyme inhibition in dogs. Circ Res 58: 874-881, 1986.
53. Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison-Bernard LM, Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev 76: 425-536, 1996.
54. Nishiyama A, Rahman M, Inscho EW. Role of interstitial ATP and adenosine in the regulation of renal hemodynamics and microvascular function. Hypertens Res 27: 791-804, 2004. (Pubitemid 40320427)
55. North RA, Surprenant A. Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 40: 563-580, 2000. (Pubitemid 30340693)
56. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 50: 413-492, 1998. (Pubitemid 28477681)
57. Randriamboavonjy V, Busse R, Fleming I. 20-HETE-induced contraction of small coronary arteries depends on the activation of rho-kinase. Hypertension 41: 801-806, 2003. (Pubitemid 36314594)
58. Sanchez-Ferrer CF, Roman RJ, Harder DR. Pressure-dependent contraction of rat juxtamedullary afferent arterioles. Circ Res 64: 790-798, 1989.
59. 6 receptors are coupled to Rho and Rho kinase activation in vascular myocytes. Am J Physiol Heart Circ Physiol 278: H1751-H1761, 2000.
60. Savineau JP, Marthan R. Modulation of the calcium sensitivity of the smooth muscle contractile apparatus: molecular mechanisms, pharmacological and pathophysiological implications. Fundam Clin Pharmacol 11: 289-299, 1997. (Pubitemid 27309864)
61. Schnermann J, Levine DZ. Paracrine factors in tubuloglomerular feedback: adenosine, ATP and nitric oxide. Annu Rev Physiol 65: 501-529, 2003. (Pubitemid 38249165)
62. Schubert R, Kalentchuk VU, Krien U. Rho kinase inhibition partly weakens myogenic reactivity in rat small arteries by changing calcium sensitivity. Am J Physiol Heart Circ Physiol 283: H2288-H2295, 2002. (Pubitemid 35345932)
63. 2+ entry blocker, CD-349, and TMB-8 on renal vasoconstriction induced by angiotensin II and vasopressin in dogs. J Cardiovasc Pharmacol 16: 966-970, 1990.
64. Takenaka T, Forster H, Epstein M. Protein kinase C and calcium channel activation as determinants of renal vasoconstriction by angiotensin II and endothelin. Circ Res 73: 743-750, 1993. (Pubitemid 23276996)
65. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389: 990-994, 1997. (Pubitemid 27485693)
66. VanBavel E, Wesselman JPM, Spaan JAE. Myogenic activation and calcium sensitivity of cannulated rat mesenteric small arteries. Circ Res 82: 210-220, 1998. (Pubitemid 28080104)
67. White SM, Imig JD, Inscho EW. Calcium signaling pathways utilized by P2X receptors in preglomerular vascular smooth muscle cells. Am J Physiol Renal Physiol 280: F1054-F1061, 2001.
68. Yiu SS, Zhao X, Inscho EW, Imig JD. 12-Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channels. J Lipid Res 44: 2391-2399, 2003. (Pubitemid 38082498)
69. Zhao X, Cook AK, Field M, Edwards B, Zhang S, Zhang Z, Pollock JS, Imig JD, Inscho EW. Impaired Ca2+ signaling attenuates P2X receptor-mediated vasoconstriction of afferent arterioles in angiotensin II hypertension. Hypertension 46: 562-568, 2005. (Pubitemid 41376838)
70. Zhao XY, Inscho EW, Bondlela M, Falck JR, Imig JD. The CYP450 hydroxylase pathway contributes to P2X receptor-mediated afferent arteriolar vasoconstriction. Am J Physiol Heart Circ Physiol 281: H2089-H2096, 2001. (Pubitemid 33121752)
71. Zhu ZM, Arendshorst WJ. Angiotensin II receptor stimulation of cytosolic calcium concentration in cultured renal resistance arterioles. Am J Physiol Renal Fluid Electrolyte Physiol 271: F1239-F1247, 1996.